DD202563A5 - Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen - Google Patents

Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen Download PDF

Info

Publication number
DD202563A5
DD202563A5 DD82242578A DD24257882A DD202563A5 DD 202563 A5 DD202563 A5 DD 202563A5 DD 82242578 A DD82242578 A DD 82242578A DD 24257882 A DD24257882 A DD 24257882A DD 202563 A5 DD202563 A5 DD 202563A5
Authority
DD
German Democratic Republic
Prior art keywords
compounds
formula
halogen
lower alkyl
hydrogen
Prior art date
Application number
DD82242578A
Other languages
German (de)
English (en)
Inventor
Henning Heinemann
Daniel Jasserand
Wolfgang Milkowski
Dimitri Yavordios
Horst Zeugner
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of DD202563A5 publication Critical patent/DD202563A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Detergent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DD82242578A 1981-08-20 1982-08-17 Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen DD202563A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813132915 DE3132915A1 (de) 1981-08-20 1981-08-20 1,5-diphenylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
DD202563A5 true DD202563A5 (de) 1983-09-21

Family

ID=6139713

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82242578A DD202563A5 (de) 1981-08-20 1982-08-17 Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen

Country Status (20)

Country Link
US (2) US4442102A (fi)
EP (1) EP0072960B1 (fi)
JP (1) JPS5839668A (fi)
AT (1) ATE43841T1 (fi)
AU (1) AU555215B2 (fi)
CA (1) CA1208643A (fi)
DD (1) DD202563A5 (fi)
DE (2) DE3132915A1 (fi)
DK (1) DK149947C (fi)
ES (1) ES515107A0 (fi)
FI (1) FI73673C (fi)
GR (2) GR76272B (fi)
HU (1) HU187572B (fi)
IE (1) IE55377B1 (fi)
IL (1) IL66580A (fi)
NO (1) NO158185C (fi)
NZ (1) NZ201643A (fi)
PH (1) PH19107A (fi)
PT (1) PT75353B (fi)
ZA (1) ZA825381B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3442860A1 (de) * 1984-11-24 1986-05-28 Kali-Chemie Pharma Gmbh, 3000 Hannover 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3- on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP1309591B1 (en) * 2000-08-14 2007-01-24 Ortho-McNeil Pharmaceutical, Inc. Substituted pyrazoles
US7589199B2 (en) 2002-06-12 2009-09-15 Chemocentryx, Inc. Substituted piperazines
JP4723242B2 (ja) 2002-06-12 2011-07-13 ケモセントリックス インコーポレーティッド 炎症および免疫障害治療用ccr1アンタゴニストとして使用するための1−アリール−4−置換ピペラジン誘導体
US20050256130A1 (en) * 2002-06-12 2005-11-17 Chemocentryx, Inc. Substituted piperazines
US7842693B2 (en) * 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
US7435831B2 (en) * 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
CA2558211C (en) * 2004-03-03 2013-09-03 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
WO2011051958A1 (en) * 2009-10-30 2011-05-05 E.I. Du Pont De Nemours And Company Fungicidal pyrazolones

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE74912C (fi) *
DE66610C (de) * FARBWERKE VORM. MEISTER LUCIUS & BRÜNING in Höchst a. M Verfahren zur Darstellung von Oxaethylmethylphenylpyrazolon
GB666578A (en) * 1948-01-10 1952-02-13 Luxema Process for the preparation of derivatives of 1, 2, 3 substituted pyrazolones and derivatives obtained by this process
US3169966A (en) * 1961-01-24 1965-02-16 Ciba Geigy Corp Aminopyrazoles
DE2824764A1 (de) * 1978-06-06 1979-12-20 Hoechst Ag Neue pyridylpiperazinderivate und verfahren zu ihrer herstellung
DE2828529A1 (de) * 1978-06-29 1980-01-17 Kali Chemie Pharma Gmbh Neue 5-phenylpyrazol-derivate, verfahren zu deren herstellung und arzneimittel

Also Published As

Publication number Publication date
EP0072960A3 (en) 1984-03-07
ATE43841T1 (de) 1989-06-15
FI822883L (fi) 1983-02-21
DK149947B (da) 1986-11-03
FI73673C (fi) 1987-11-09
NO822827L (no) 1983-02-21
NO158185C (no) 1988-07-27
DK149947C (da) 1987-06-15
IL66580A (en) 1985-10-31
DE3279756D1 (en) 1989-07-13
IE55377B1 (en) 1990-08-29
JPH0375542B2 (fi) 1991-12-02
US4442102A (en) 1984-04-10
IE822002L (en) 1983-02-20
GR78228B (fi) 1984-09-26
PH19107A (en) 1986-01-02
EP0072960B1 (de) 1989-06-07
ES8306143A1 (es) 1983-05-01
JPS5839668A (ja) 1983-03-08
ES515107A0 (es) 1983-05-01
HU187572B (en) 1986-01-28
FI822883A0 (fi) 1982-08-19
EP0072960A2 (de) 1983-03-02
PT75353B (en) 1984-08-01
IL66580A0 (en) 1982-12-31
CA1208643A (en) 1986-07-29
GR76272B (fi) 1984-08-04
NZ201643A (en) 1985-04-30
FI73673B (fi) 1987-07-31
AU555215B2 (en) 1986-09-18
NO158185B (no) 1988-04-18
AU8742482A (en) 1983-02-24
ZA825381B (en) 1983-05-25
DE3132915A1 (de) 1983-03-03
PT75353A (en) 1982-08-01
US4515944A (en) 1985-05-07
DK372382A (da) 1983-02-21

Similar Documents

Publication Publication Date Title
EP0136658B1 (de) 1-Benzyl-aminoalkyl-pyrrolidinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
DE1695556B2 (de) 3Alkyl-l,2,3,4,4a,9-hexahydropyrazino [1,2-f] morphanthridinderivate
EP0047923B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0163260B1 (de) Neue substituierte Pyrrolidinone, Verfahren zu ihrer Herstellung und Arzneimittel
DD209446A5 (de) Verfahren zur herstellung von neuen aromatischen verbindungen
DE2628189A1 (de) 3-phenylindoline, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0072960B1 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2811031A1 (de) Piperazin-3-indole, verfahren zu ihrer herstellung und ihre therapeutische verwendung
EP0019172A1 (de) 6-Substituierte 11-Alkylen-morphantridine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
DD145104B3 (de) Verfahren zur herstellung von polyalkoxyphenylpyrrolidone
DD236928A5 (de) Verfahren zur herstellung neuer 1,2,4-triazolo-carbamate
EP0170861B1 (de) 3-Aminocarbonylmethoxy-5-phenylpyrazol-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2429290A1 (de) Tricyclische kondensierte imidazolderivate und verfahren zu ihrer herstellung
EP0072961B1 (de) 1-Phenylindazol-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3532279A1 (de) 1,4-benzoxathiin-derivate
DE2929760C2 (fi)
DD219642A5 (de) Verfahren zur herstellung von bis-(piperazinyl- bzw. homopiperazinyl)alkanen
DE2605824A1 (de) N-acylaniline, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69225381T2 (de) Nootrope Wirkstoffe
DE2903048A1 (de) Ergolinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0000479A1 (de) Substituierte 1-Piperazinyl-4H-s-triazolo (3,4-c)thieno(2,3-e)1,4-diazepine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3540702A1 (de) 1h-pyrido-(2,3-b) (1,4)-thiazine
CH421121A (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
DE3701737A1 (de) 1h-pyrido-(2,3-b)(1,4)-thiazine zur therapeutischen behandlung